German chemicals giant BASF sounds out Evonik over potential takeover
25.09.2026,
dpa
German specialty chemicals group Evonik confirmed on Friday that larger rival BASF has made a non-binding approach over a possible takeover of the Essen-based company.
BASF has also later confirmed exploratory contacts with Evonik and its largest shareholder, the RAG Foundation, over a potential acquisition.
"The course and outcome of the exploratory talks are currently open," the Ludwigshafen-based chemicals giant said.
Evonik said BASF's non-binding approach concerned a possible voluntary public takeover offer for all of the company's shares.
But no talks are currently taking place, it added.
BASF said it regularly examines potential acquisitions as part of its corporate strategy, including deals that could strengthen its core businesses and promote profitable growth and value creation.
The confirmations followed reports by the Financial Times and Bloomberg. According to Bloomberg, BASF has been exploring a possible deal with advisers for several months.
The Financial Times, citing people familiar with the matter, reported that BASF had discussed a potential takeover not only with Evonik but also with the RAG Foundation.
The foundation confirmed that BASF had approached it about a possible voluntary public takeover offer but declined to comment further.
The RAG Foundation holds around 43.8% of Evonik, meaning its position would be crucial to any potential deal. It also noted that it currently has three outstanding bonds carrying rights to be exchanged for Evonik shares.
BASF seeks to strengthen position
According to the Financial Times, BASF sees an acquisition as a way to expand its geographic footprint and product portfolio and strengthen its position against Chinese competitors.
A takeover would be a major deal given Evonik's market capitalization of more than €8 billion ($9.1 billion).
The potential deal comes as the chemicals industry grapples with sharply higher energy costs stemming from the war in the Middle East, although shortages of some products have allowed certain companies to benefit from higher selling prices.
BASF has been cutting jobs and restructuring its operations. The company said in July that it had eliminated around 7,000 jobs worldwide between January 2024 and the end of June 2026.
At the same time, higher prices allowed BASF chief executive Markus Kamieth to raise the company's profit forecast for the current year.
Alongside job cuts, particularly at its main Ludwigshafen site, BASF has been reshaping its portfolio.
At the end of June, it completed the sale of a 60% stake in its automotive coatings business to US investment firm Carlyle. BASF retains 40% of the resulting joint venture, Surventis, but ultimately plans to exit the business completely.
The company also plans to list its agricultural business on the Frankfurt stock exchange.
Evonik also cutting costs
Evonik is also pursuing cost reductions despite raising its earnings outlook over the summer.
The company plans to cut another 3,200 jobs by the end of 2029, including 2,150 in Germany. It has also announced plans to discontinue its unprofitable polyester business, which generates annual sales of around €150 million.
Evonik is also withdrawing from commodity businesses, with further divestments planned. The company is seeking to separate its standard chemicals activities in the Performance Materials division.
Chief executive Christian Kullmann is currently absent due to illness following an operation, with Asia chief Claus Rettig standing in for him.














